Dispatched Within 24 Hours
Referenced in Human Studies
Third-Party COA Verified
Sourced from Trusted Labs in EU
Scientific Advisory Oversight
Tesamorelin, is a growth-hormone-releasing hormone (GHRH) analogue researched for the treatment of HIV-associated lipodystrophy (dysfunctional fat deposition). It is also being researched for its ability to improve peripheral nerve health, slow the progression of mild cognitive impairment, and the reduction fat mass..
Our local team are here to help
Have more questions about peptide research? You’re not alone. Explore our Frequently Asked Questions for quick answers—or head to the Knowledge Base to explore study areas, calculators, and protocol guides.
Tesamorelin is commonly studied for its role in supporting growth hormone release and changes in body composition under controlled lab conditions.
It’s typically reconstituted with bacteriostatic water using sterile technique, then stored in refrigeration.
Daily use is common in research studies exploring short-acting growth hormone–related pathways.
Yes, it’s often included in GH axis research stacks to study potential synergy with other secretagogues.
Keep the reconstituted solution refrigerated and shielded from light for optimal stability.